BioMerieux SA
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About BioMerieux SA
BioMérieux designs, develops, and manufactures a broad portfolio of in vitro diagnostics for detecting disease-causing pathogens and contamination. The company operates in four segments: molecular biology (42% of 2024 sales), microbiology (33%), immunoassays (10%), and industrial applications (about 15%). The Americas account for the largest portion of the firm's revenue (40%), followed by Asia-Pacific (27%) and Europe, the Middle East, and Africa (27%). BioMérieux is headquartered in Marcy-l'Étoile, France.
/ 
Frequently asked questions
To buy BioMerieux SA stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for BioMerieux SA by name or ticker, choose the number of shares, and place your order.
The ticker symbol for BioMerieux SA is BIM:xpar. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
BioMerieux SA has its primary listing on Euronext Paris. You can trade BioMerieux SA with a Saxo account, alongside thousands of other stocks worldwide.
Yes, BioMerieux SA is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include BioMerieux SA as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like BioMerieux SA.